Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bramitob in Cystic Fibrosis and Chronic Pseudomonas Aeruginosa Infection (CT03Ext)
NCT01111383Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of tobramycin in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2009; status: completed.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01111383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111383.